(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. Depletion of XlPouV proteins causes posterior truncation and anterior
defects. (A) In vitro translation assay. The antisense MOs
specifically prevent translation of their target mRNA but not the
non-complementary (NC) mRNA. 3xMO indicates that a mix of all three
XlpouV MOs was used. Capped mRNAs (1 µg) were used for translation and MOs
were used at a concentration of 1 µM. (B) Two-cell stage embryos
were injected in both blastomeres with control MO or XlpouV MO, and the
octamer binding motif or the Fgf4 enhancer luciferase reporters. Embryos were
assayed for luciferase activity at stage 9.5. The experiment was carried out
in triplicate. (C) Two-cell stage embryos were injected in both
blastomeres with 60 ng (control MO only) or 20 ng of each indicated MO and
collected at stage 40. The term XlpouV MO was used to indicate that all three
MO had been injected simultaneously.